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Abstract
Context: Cortisol is released in ultradian pulses. The biological relevance of the resulting fluctuating cortisol concentration
has not been explored.
Objective: Determination of the biological consequences of ultradian cortisol pulsatility.
Design: A novel flow through cell culture system was developed to deliver ultradian pulsed or continuous cortisol to cells.
The effects of cortisol dynamics on cell proliferation and survival, and on gene expression were determined. In addition,
effects on glucocorticoid receptor (GR) expression levels and phosphorylation, as a potential mediator, were measured.
Results: Pulsatile cortisol caused a significant reduction in cell survival compared to continuous exposure of the same
cumulative dose, due to increased apoptosis. Comprehensive analysis of the transcriptome response by microarray
identified genes with a differential response to pulsatile versus continuous glucocorticoid delivery. These were confirmed
with qRT-PCR. Several transcription factor binding sites were enriched in these differentially regulated target genes,
including CCAAT-displacement protein (CDP). A CDP regulated reporter gene (MMTV-luc) was, as predicted, also
differentially regulated by pulsatile compared to continuous cortisol delivery. Importantly there was no effect of cortisol
delivery kinetics on either GR expression, or activation (GR phosphoSer
211).
Conclusions: Cortisol oscillations exert important effects on target cell gene expression, and phenotype. This is not due to
differences in cumulative cortisol exposure, or either expression, or activation of the GR. This suggests a novel means to
regulate GR function.
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Introduction
Glucocorticoids undergo a circadian oscillation, with cortisol
levels in humans peaking in the early morning and subsequently
decreasing to low levels in the evening [1–5]. These diurnal
fluctuations arise from signaling between the hypothalamic
suprachiasmatic nucleus and the adrenal gland, and consist of
both the autonomic nervous system and hormonal regulation of
the HPA axis [6,7]. Additionally, ultradian rhythms of cortisol
exist in healthy human volunteers, with a pulse of production
every 1–2 hours [8,9]. These secretory episodes occur with a
constant frequency, but a variable amplitude, allowing for the
production of the subsequent circadian rhythm [10–16].
Glucocorticoids mediate their effects through the intracellular
glucocorticoid receptor (GR). There are rapid effects on intracel-
lular signaling kinases [17], and effects on target gene transcription
[18–22]. The activated GR can either bind directly to target DNA
sequences, or via a tethering mechanism to other, DNA-bound
transcription factors, including NFkB, AP-1, HNF4, C/EBP and ets
[18,23,24]. There is evidence that activated nuclear receptors,
including GR, are highly dynamic within living cells, suggesting a
‘‘hit and run’’ mechanism for target gene regulation, coupled to a
highly ordered cycle of chromatin remodelling [19,25–27]. The
intrinsic temporal dynamics of this system exist with constant ligand
exposure, but the impact of temporal fluctuations in ligand
availability, likely the situation seen in-vivo, is unknown [11,28].
Recent studies have revealed unexpected, rapid, ligand-driven
changes in GR-DNA interactions, with consequences for target
gene transcription. Such changes were only seen with low-affinity,
endogenous GR ligands, and not with the higher affinity synthetic
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studies suggest that the evolutionary conservation of glucocorticoid
pulsatile release has consequences for the biologically accurate
expression of patterns of genes [29].
Glucocorticoids are used extensively as anti-inflammatory
agents but are difficult to use long-term because of serious
metabolic side-effects (ie hypertension, hyperglycaemia, hyperlip-
idaemia, osteoporosis, gastric ulceration, glaucoma). Current oral
maintenance glucocorticoid treatment, used for multiple chronic
inflammatory diseases, delivers one large dose of a synthetic
glucocorticoid with a prolonged biological half-life.
In this study we use flow through cell culture to deliver pulsed
and continuous cortisol to HeLa cells. Gene expression profiling
and bioinformatic analysis shows differential expression and
indicates that the temporal kinetics of cortisol delivery significantly
alters the cellular response.
Materials and Methods
Flow-through culture system
A flow-through cell culture system with integrated cell culture
chamber was designed. The system was driven using a peristaltic
pump (Watson-Marlow Bredel Pumps), maintained in a 37uC
incubator. An externally controlled pinch valve allowed the flow of
medium to be switched between alternative medium reservoirs,
allowing the temporal delivery of compounds without perturbation
to the target cells.
Pulse modelling. Recording cortisol levels: The flow-through
cell culture system was optimised to replicate endogenous cortisol
pulses. A single, complete pulse was performed using the flow-
through system. 361 ng/ml (1 mM) cortisol medium was infused for
10 or 20 minutes, followed by switching to non-cortisol containing
medium container for 50 mins. The flow rate was 14 ml/h. Samples
were collected every 5 minutes from the effluent tube and cortisol
levels were measured using a cortisol ELISA system (R&D Systems).
Treatment schedules
Approximately 1610
6 HeLa cells were seeded into the flow-
through culture dishand left for 24 hrs(100%confluent). Cells were
washed with PBS. 5 mls of FBS-free flow-through medium with
bicarbonate levels optimised for buffering with air was added and
the dish sealed. Untreated control: One input reservoir contained
flow-through medium (RPMI 1640+10% FBS). A continuous 14 h
treatment was given using the flow-through medium alone.
Pulsatile cortisol treatment
The two input reservoirs contained either flow-through medium
or flow-through medium with 361 ng/ml (1 mM) cortisol. The
cells were given pulses of the cortisol medium for 10 minutes
followed by a 50 minutes washout period. This was repeated
twelve times, at hourly intervals, followed by a 2 hr washout
period using the flow-through medium. Infusion of cortisol
containing medium for 10 minutes gave approximately 200 ng/
ml cortisol peaks in the cell culture vessel.
100 ng/ml cortisol continuous treatment
The two input reservoirs, one containing serum free flow-
through medium, and the other flow-through medium with
100 ng/ml (277 nM) cortisol. A continuous 12 hour treatment
of 100 ng/ml was followed by a 2 hr washout period using the
flow-through medium alone. This delivered the same total amount
of cortisol to the target cells over 12 hours as the continuous
pulsatile delivery system, and was therefore a matched cortisol
dose control.
200 ng/ml cortisol continuous treatment
The two input reservoir contained either flow-through medium
or flow-through medium with 200 ng/ml (554 nM) cortisol. A
continuous 12 hour treatment of 200 ng/ml was followed by a
2 hr washout period using the flow-through medium alone. The
200 ng/ml continuous treatment equated to the concentration at
the peak of the pulse.
Therefore, all the cells received flow-through medium, and the
same rate was used for all studies.
The 200 ng/ml treatment was used for the microarray
experiments only.
Cell proliferation assay
HeLa cells were plated, and cultured as per the treatment
schedules described above. After 14 hours conditioning viable cells
were counted, by trypan blue exclusion, using a haemocytometer
by a masked observer.
HeLa cell apoptosis assay
Cells were seeded at 2610
6/ml overnight. Adherent HeLa cells
were exposed to pulsatile (100 ng/ml), continuous (100 ng/ml) or
control for 12 hrs, followed by a final 2 hrs cortisol-free washout
period. The cells were then washed with PBS and labelled with
APC conjugated-Annexin V and analysed with FACS.
RNA extraction
Total RNA was extracted using RNeasy Mini Kit (Qiagen).
RNA quality was checked using the RNA 6000 Nano Assay, and
analyzed on an Agilent 2100 bioanalyser (Agilent Technologies).
RNA was quantified using a Nanodrop ultra-low-volume spectro-
photometer (Nanodrop Technologies). RNA samples required a
260:280 nM ratio of .1.9 to be analysed further.
cDNA synthesis
Approximately 100 ng total RNA was used to synthesize cDNA.
Synthesis was carried out using a Two-Cycled cDNA Synthesis Kit
(Affymetrix). A GeneChip Sample Clean Up Module kit
(Affymetrix/QIAGEN) was used for cDNA cleanup. The final
elution step resulted in approximately 12 ml cDNA. Quality of the
cDNA was checked using the RNA 6000 Nano Assay and
analyzed on an Agilent 2100 Bioanalyser.
Biotinylation and fragmentation of cRNA
Biotin labeling of cRNA was carried out using Genechip IVT
labeling kit (Affymetrix). 12 ml of cDNA was used and the resultant
cRNA was purified using the GeneChip Sample Clean-up Module
with a final elution volume of 19 ml in RNase free water. cRNA
was quantified using the Nanodrop spectrophotometer. 15 mg
cRNA was used for fragmentation. The reaction was carried out in
5X fragmentation buffer at 94uC for 35 min.
Hybridization
Affymetrix HG U133A chips were hybridized with the labeled
cRNA, and then scanned, as previously described [30].
Array analysis
Details are contained in the Supplementary Materials S1.
Transcription factor activity informatics
Modeling and visualising transcription factor (TF) networks was
based on the principles of Xie et al.[31] and of Sanguinetti
et al.[32]. This utilises both predicted transcription factor binding
sites (TFBS), transcription factor abundance, and our microarray
Pulsatile Glucocorticoid Action
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used are provided in the Supplementary Materials S1.
Real-time qPCR
qRT PCR was carried out according to manufacturers
instructions. Details are provided within the Supplementary
Materials S1.
Luciferase reporter gene assay
HeLa cells (2610
6) were plated and transfected with 2 mg mouse
mammary tumour virus-luciferase (MMTV-Luc) plasmid and
0.1 mg Renilla luciferase plasmid using FUGENE transfection
reagent (Roche) according to the manufacturer’s instructions.
Cells were exposed to either control (normal flow through
medium, no cortisol), continuous flow with cortisol 100 ng/ml
or dose-equivalent pulsatile cortisol (total amount delivered
100 ng/ml). After 12 h, a cortisol-free washout period of 2 hours
was performed. Cells were washed twice in PBS, lysed, and
MMTV-Luc and Renilla-Luc activity measured using the dual
luciferase reporter gene assay. Relative luminescence units were
calculated.
Immunoblot analysis of GR
Cells were lysed in radioimmunoprecipitation assay buffer
(RIPA) buffer (50 mM TrisCl pH 7.4, 1% NP40, 0.25% Na-
deoxycholate, 150 mM NaCl, 1 mM EDTA, and Complete
protease inhibitor (Roche), with phosphatase inhibitor cocktail 1
and 2 (Sigma)) and complete protease-inhibitor cocktail. Protein
concentration was determined using the Bio-Rad Bradford assay
reagent. Whole cell lysates (75 mg protein) were resolved by SDS-
PAGE, blotted, and membranes incubated with primary antibod-
ies (Mab GR - BD Transduction Labs, and P-GR (Ser211) – Cell
Signalling Technologies). Membranes were subsequently stripped
and blotted for a-tubulin to confirm equal loading of samples and
transfer of protein, as described before [17,30]. Immunoblots
analysis was performed on two separate cell incubations.
Figure 1. Establishment of flow through culture system to analyse pulsatile glucocorticoid action. (A) Pulse modeling using cortisol
ELISA. The cell chamber was infused with cortisol containing flow-through medium for 10 minutes (Black), and then the input reservoir was switched
to medium without cortisol for 50 mins. Effluent medium was collected every 5 minutes for ELISA analysis. Endogenous rat corticosterone
concentrations are plotted (Grey) are re-plotted for comparison [13] (B): Simulated data for the various cortisol treatment schedules: Pulsed treatment
(200 ng/ml cortisol every hour), continuous 100 ng/ml cortisol and continuous 200 ng/ml cortisol. After 12 hours, a cortisol-free washout period of
2 hours was performed. Cells were then harvested for analysis.
doi:10.1371/journal.pone.0015766.g001
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Where comparisons between two groups are made unpaired
Student’s t test was used, and where comparison was between
more than two groups initial analysis was by ANOVA, followed by
post hoc Bonferroni t test.
Results
Cortisol pulse modelling
A cortisol ELISA was used to calibrate the flow through system to
replicate endogenous cortisol pulses (Figure 1A). The culture dish was
infused with the cortisol flow-through medium for 10 or 20 minutes,
and then input wasswitched to the cortisol-free flow-through medium
for 50 minutes. An endogenous rat pulse of corticosterone, as
measured by the automated frequent blood sampling technique
developed by Lightman [11,14], is included on the graph as a
reference. The 20 minute infusion of cortisol medium resulted in a
peak cortisol concentration in excess of 350 ng/ml. However, the
cortisol medium for 10 minutes, followed by a 50 minute washout
period, produced a pulse that closely replicated the endogenous
corticosterone rhythm seen in-vivo in frequently sampled rats.
In order to investigate the effect of temporal cortisol levels on
target cell response appropriate treatment schedules were
designed. The dosing schedules were; untreated control, contin-
uous treatment, pulsatile treatment, and concentration control
(Figure 1B). After each treatment schedule cell analysis was
performed or RNA was extracted from the HeLa cells for
microarray analysis. In all cases a 2 h washout period was used to
avoid the acute impact of final cortisol concentration.
Cell proliferation and 3viability. Initial assessment of the
effects of cortisol dynamics on HeLa cell proliferation and viability
was carried out. Pulsatile cortisol caused a significant reduction in
live cell survival compared to continuous exposure, reflecting a
complex cell response to cortisol delivery kinetics (Figure 2A).
To determine the contribution of apoptosis to the variation in
cell viability observed HeLa cells were exposed to the identical
treatment regime as used for the cell viability assay, and then
Annexin V staining determined by FACS. This confirmed that the
reduction in cell viability and cell proliferation observed was due,
at least in part, to increased apoptosis (Figure 2B).
Glucocorticoid target gene profiling. In order to further
explore the effect of cortisol dynamics on target cell response we
used an unbiased strategy of expression gene profiling. An
overview of the analysis plan for the resulting microarray data is
shown in Figure S1.
Global gene expression changes in our dataset were explored by
principal components analysis (PCA) to reveal the relationships
between the different cortisol delivery regimes [33]. Plotting array
samples in PCA space shows that cortisol treatment has a major
effect on the gene expression profile (Figure 3A). The first principal
component (x-axis; PC#1) accounts for the largest component of
gene expression change in the dataset, and therefore the biggest
differences between arrays. This first component showed that
pulse treatment separates from control in a similar way to 100 ng/
ml (C100) and 200 ng/ml (C200) treatment (Figure 3A). However,
when PCA is done without the control treatment, the pulse
treatment replicates separated from both continuous treatments on
component 3 (Figure 3B; y axis, PC#3). Taken together these
results indicated that pulse treatment was largely similar to C100
and C200 treatments, but that pulse delivery does cause weaker
but identifiable gene expression differences from continuous
delivery.
A detailed description of the analysis strategy for the microarray
data is given in Supplementary Materials S1. We used DAVID
software to group the regulated genes according to function [34].
This gene classification was done on the pool of all 469
differentially expressed genes. Significant over-representation of
genes associated with cell adhesion (Benjamini corrected p-value
6.8610
24) was found, as well as mitotic cell cycle (Benjamini
corrected p-value ,0.1); graphically presented in Fig. S2.
The cluster heat map of cell adhesion genes affected by the
mode of cortisol delivery is shown in Figure 4A. Of the six genes
selected, ITGA5 was upregulated more by pulsatile delivery of
cortisol, compared to continuous, and COL7A1, GPR56 and
ADAM12 were all significantly repressed to a greater extent by
continuous cortisol compared to pulse (Figure 4B-G). The
expression of ITGA10 was increased more by continuous than
pulsatile cortisol, and the expression of CD97 was down-regulated,
by all cortisol treatments (Figure 4 B-G). In addition to these cell
adhesion genes, the expression of an additional nine genes from
other functional groups was assessed by qRT-PCR (Fig. S3) to
validate array results. All of these genes were shown to be
regulated by glucocorticoids and for three of these (the GR,
NR3C1; NR6A1 and FKBP5), there was a significantly different
effect seen between C100 and pulsatile delivery.
MAOA was predicted by the microarray to be induced to a
greater extent by continuous cortisol, and this was seen by qRT-
Figure 2. Glucocorticoid delivery kinetics affect target cell
proliferation, and apoptosis. (A) Glucocorticoid regulation of cell
proliferation. HeLa cells were seeded at 2610
6 per well and subjected
to either control (normal flow through medium, no cortisol), continuous
flow with cortisol 100 ng/ml, or dose-equivalent pulsatile cortisol. After
16 hours cells were counted using a haemocytometer. The experiment
was performed in triplicate, bars indicate mean and SEM. Comparison
was by ANOVA, and post hoc Bonferroni t test * indicates p,0.01.
(B) Effects of pulsatile and continuous hydrocortisone (Hc) on induction
of apoptosis in HeLa cells. Cells were seeded at 2610
6/ml overnight.
Adherent HeLa cells were exposed to pulsatile (100 ng/ml), continuous
(100 ng/ml) or control (no Hc) for 12 hrs. The cells were then washed
with PBS and labelled with APC conjugated-Annexin v and analysed
with FACS. Data shown are the relative fold increase in induction of
apoptosis by pulsatile treatment compared to the continuous Hc. Graph
is mean of n=3 experiments. Comparison was by ANOVA followed by
post hoc Bonferroni t test * indicates p,0.001.
doi:10.1371/journal.pone.0015766.g002
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was induced to a similar extent by both pulsatile, and continuous
cortisol in both the array, and the qRT-PCR. MAP3K7 was
predicted by the microarray to be repressed to a greater extent by
pulsatile cortisol, and this effect was not confirmed by qRT-PCR
measurement.
Figure 3. Microarray analysis of the transcriptome response to pulsatile versus continuous glucocorticoid treatment. (A) Principal
components analysis (PCA) of microarray data to establish relationships between the samples using all genes in the microarray dataset. Control,
pulsatile cortisol delivery (PULSE), continuous 100 ng/ml (100), and continuous 200 ng/ml (200) are indicated on the plots. There is a clear separation
between all the cortisol treatments and control in the first component. (B) When cortisol treatments are considered separately pulsatile treatment
segregates from the two continuous treatments in the third component.
doi:10.1371/journal.pone.0015766.g003
Figure 4. Gene ontology analysis of the transcriptome response to pulsatile versus continuous glucocorticoid treatment. (A) Cortisol
regulated genes with a differential response to pulsatile versus continuous 100 ng/ml delivery were analysed by DAVID gene ontology software.
Probe set, gene abbreviation, heat map of microarray expression and hierarchical clustering are shown. Red and green indicate positive and negative
deviation from mean, respectively, with the intensity of colors representing the extent of deviation. Cluster transcripts levels of .5% were required to
include a particular biological process or pathway. Black arrows indicate genes validated by qRT-PCR. (B–G) Quantitative RT-PCR validation of
microarray data. Confirmation of the microarray results were sought using expression analysis of the indicated genes by quantitative real time PCR.
All expression values were normalised to the average of b-actin and GAPDH. Data represents the mean and standard error of biological triplicate
experiments. Data was analysed by unpaired Student’s t test, exact P values are shown. qPCR data is indicated by solid bars while array data is
indicated by hatched bars.
doi:10.1371/journal.pone.0015766.g004
Pulsatile Glucocorticoid Action
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strategy for modeling and visualising transcription factor (TF)
networks that utilises predicted transcription factor binding sites
(TFBS), transcription factor abundance, and our microarray based
gene expression data was employed (Fig. S4). This predicted
differential activity of several transcription factors including SP-1,
and CDP (Figure 5 A-D). CDP was of interest as a regulator of the
mouse mammary tumor virus (MMTV), which is also known to be
glucocorticoid responsive [35]. Importantly, pulsatile and
continuous cortisol exerted quite different effects on MMTV
promoter activity, as predicted (Figure 5E).
Immunoblot analysis of total GR and phospho-GR. As
the principal mediator of glucocorticoid action is likely to be the
GR itself, and expression of the GR gene (NR3C1) was
differentially affected by delivery kinetics, the expression level of
the GR protein was assessed. There was no apparent difference in
the ligand dependent repression of GR expression seen under any
of the experimental conditions observed (Figure 6). Moreover, the
induction of phosphorylated Ser
211GR also was similar (Figure 6).
Discussion
The existence of pulsatile release of glucocorticoids from the
adrenal glands, and the attendant pulsatility of serum levels have
been known for some time [13]. However, the downstream
implications of such short-term fluctuations in serum concentra-
tion for glucocorticoid action on target tissue have not been
explored. Indeed, therapeutically, there has been a move towards
Figure 5. Analysis of possible transcription factor regulatory networks driven by pulsatile versus continuous glucocorticoid
treatment. (A) The significantly different (SigDiff) transcription factor activities (TFAs) in the continuous cortisol treatment (100 ng/ml) (CCT)
compared with the pulsatile cortisol treatment (PCT) (of matched dose) are presented in the limpet-like plots. A line presents a SigDiff TFA between
the strengths of the TFA of the PCT and the CCT. If a SigDiff is greater than zero, it is displayed in bluish color and indicates that the TFA for the TF-
gene pair is significantly higher in the PCT (Down-regulation in the CCT); while, if a SigDiff is less than zero, it is displayed in reddish color and
indicates that the TFA for the pair is significantly higher in the CCT (Up-regulation in the CCT). (B) A break-down view for the 6 TFs showing the
biggest differences between PCT and CCT (especially C100). To highlight the SigDiff TFAs for the 6 TFs, other SigDiff TFAs are dimmed out. (C) The
perimeters of the plots are broken into different coloured regions corresponding to the different functional groups which are listed in the key. (D) The
legend for line color. (E) Experimental validation of transcription factor analysis. 2610
6 HeLa cells were plated and transfected with 2 mg mouse
mammary tumour virus-luciferase (MMTV-Luc) plasmid and 0.1 mg Renilla luciferase plasmid. Cells were exposed to either control (normal flow
through medium, no cortisol), continuous flow with cortisol 100 ng/ml or dose-equivalent pulsatile cortisol (total amount delivered 100 ng/ml). After
12 hours, a cortisol-free washout period of 2 hours was performed. Cells were washed twice in PBS, lysed, and MMTV-Luc and Renilla_Luc activity
measured using the dual luciferase reporter gene assay. Relative luminescence units were calculated. Comparison between the continuous and
pulsatile exposures was by unpaired Student’s t test. The graph is representative of two independent experiments, each performed in triplicate.
** indicates p,0.001.
doi:10.1371/journal.pone.0015766.g005
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way of improving patient compliance. In this current work, we
have sought to explore the biological consequences of short-term
fluctuations in glucocorticoid concentrations for the target cell
response.
Detailed physiological studies have generated high resolution plots
of varying glucocorticoid concentrations over time, with an estimated
inter pulse period of 80–120 mins [36]. Our study design replicated
pulse characteristics in-vitro. A cortisol conditioning period followed
by a hormone free wash-out period was adopted This had the
advantage of conditioning cells with either pulsed or continuous
glucocorticoid but the hormone free wash out period avoided the
potential confounding factor of the different final concentration of
cortisol in the cell culture medium. Initial experiments demonstrated
significant effects of the cortisol dynamics on HeLa cell proliferation
and apoptosis. Principal components analysis (PCA) of the micro-
array data, with separation of control samples from cortisol
treatments, indicated that the main patterns of gene expression
responses were similar regardless of cortisol delivery regime. PCA in
the absence of control samples showed separation of pulsed delivery
samples from low and high dose continuous cortisol treatments. This
implies that the pulse mode of cortisol delivery exerts an impact on
the pattern of gene regulation in target cells.
The objective of the microarray analysis was to identify networks
of genes whose expression were differentially regulated by the
different modesofglucocorticoiddelivery,andthe analysisstrategyis
outline in Fig. S4. No genes passed our initial strict criteria for
differential expression between the different cortisol regimes,
although a large number did in the comparisons to control.
Compared with the control, cortisol treatments showed differential
regulation of genes involved in cell adhesion, cell cycle, and
cytoskeleton. Employing less stringent criteria for differential gene
expression between pulse and continuous deliveries it was found that
genes involved in cytoskeleton and cell adhesion were influenced by
pulse delivery. Significant differences in gene expression were also
seen using qRT-PCR. It is relevant that cytoskeleton, and cell
adhesion genes are known to be targets for Gc action, as previously
reported [37]. The differences discovered here are predicted to alter
the final impact of Gc on cell phenotype, and provide an attractive
molecular mechanism to explain the altered impact of Gc on cell
proliferation, and apoptosis presented in figure 2.
Transcription factors differentiating between the delivery modes
of cortisol further were also identified in silico, and one, CDP, was
robustly validated experimentally.
Recent work has discovered that pulsatile delivery of the rodent
physiological glucocorticoid, corticosterone, results in rapid
oscillations of GR on and off target genes. These cycles correlate
with pulses of gene transcription, or ‘‘gene pulsing’’[29]. This
suggests that naturally occurring pulses of glucocorticoid delivery
have an important regulatory effect on expression of the target cell
genome. In these studies continuous corticosterone delivery was
compared against the same concentration given in pulses, with a
resulting reduction in the cumulative glucocorticoid dose. This
design differs importantly from our current work, in which the
conditioning effect of pulsatile, and concentration matched cortisol
cumulative doses were achieved. It is striking that in the earlier
work continuous corticosterone consistently had a greater effect on
target gene induction, and subsequent protein accumulation
compared to pulsatile delivery [29]. We now show that dose-
matched pulsatile delivery of cortisol exerts a greater effect on
expression of some target genes, and a lesser effect than continuous
cortisol on others, reflecting perhaps differences in the GR-target
DNA sequence interaction.
A major determinant of the glucocorticoid response is the
expression level of the GR. We found no significant differences in
total GR protein expression, or in the activation of GR, as
measured by GR phosphorylation of Ser
211, in response to
pulsatile or continuous glucocorticoid exposure.
Differential effects of pulsatile delivery on target gene expression
may be related to an underlying mechanism controlling GR
cycling on target regulatory elements. For instance, Stavreva et al.
has described fluctuations in glucocorticoid concentration to be
followed by a rapid response of the activated GR cycling on and
off target gene regulatory elements [29]. Furthermore, it is likely
that DNA sequence differences, taken with the wider context of
the regulated gene, may affect the on and off rates for GR binding,
and as a consequence make some genes more critically dependent
on ligand bound GR than others. Indeed, very recent work has
discovered significant GR binding to the genome even in the
absence of ligand binding, and changes in GR binding to the
genome dependent on corticosteroid concentration, underlining
the complex relationship between ligand binding and target gene
recognition and regulation [38].
In summary, our data define a role for rapid fluctuations in
glucocorticoid concentration on target gene regulation, and
provides a possible biological impact for the physiological
fluctuations in serum glucocorticoid concentrations. We describe
an important frequency modulation ‘‘FM’’ signal encoded by
pulsatile adrenal release of glucocorticoids capable of delivering an
additional level of information to target cells. This has implications
for therapeutic glucocorticoid drug design and also for the
administration of glucocorticoid drugs.
Supporting Information
Supplementary Materials S1 Analysis strategy, and method-
ology applied to gene expression analysis. The supplementary
materials detail the analytical approach, and the methods
employed to profile, and validate gene expression profiles in cells
subjected to either pulse, or continuous glucocorticoid. The
initial results of such analysis are presented, with additional qRT-
PCR validation. The primer sequences used for qRT-PCR are
also presented.
(DOC)
Figure S1 Gene expression array profiling: Flow chart
showing data analysis strategy. Initial review of the data
used gcRMA, then initial analysis was by Limma and q value, and
Figure 6. Expression of total GR and Ser 211 phosphorylated
GR (P-GR) in HeLa cells after different flow-through schedules.
Cells were set up and treated with control (C), pulse (P), c100 (C1),
& c200 (C2) treatment schedules, as for the microarray experiments.
Whole cell extracts were prepared and immunoblotting was performed
using the indicated antibody.
doi:10.1371/journal.pone.0015766.g006
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PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e15766principal component analysis. Two thresholds were applied for
more detailed analysis, a strict, and a more lenient one. Resulting
gene lists were analysed by DAVID for functional networks, and
then by hierarchical clustering, and volcano plotting.
(TIF)
Figure S2 Volcano plots showing the magnitude of
change in gene expression between pulse and continuous
(C100) treatments. Genes expressed more highly under pulse
conditions are shown to the right of the ‘‘y’’ axis, which depicts the
(-Log10) of the P value. Cell adhesion genes (a – in blue) and cell
cycle genes (b – in blue) that are differentially expressed between
the two treatments are indicated.
(TIF)
Figure S3 Quantitative RT-PCR validation of microar-
ray data. Confirmation of the microarray results were sought
using expression analysis of the indicated genes by quantitative
real time PCR. All expression values were normalised to the
average of b-actin and GAPDH. Data represents the mean and
standard error of biological triplicate experiments. Exact P values
are shown, analysis by Student’s t test.
(TIF)
Figure S4 Overview of our systematic approach. The
data analysis pipeline is composed of five parts: (1) RMA
normalization of microarray data is performed, and a binary
matrix containing connection topology is constructed. (2) The
microarray data and connectivity data are utilized to infer TFAs
and TFCs. (3) Once TFAs are estimated, the statistically SigDiffs
are calculated. (4) SigDiff TFAs and TFs are analyzed and
classified into structural groups and functional groups. (5) The
SigDiff TFAs and TFCs are illustrated with TF-perspective views
that show TFAs with associated TFCs by TF functional group and
experimental condition and round limpet-like plots which show
the TFA between individual TF and genes.
(TIF)
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